Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 30 2014
Print

Breaking News

November 21, 2011
Internal review reveals maintenance missteps  Read More »
November 21, 2011
Gains clinical-stage HCV drug candidates  Read More »
November 21, 2011
NJ facility will house management, administration, commercial operations, manufacturing, and product development  Read More »
November 21, 2011
Will also provide IVRS, data management and central lab services for trials  Read More »
November 18, 2011
Will jointly develop and commercialize products in Japan  Read More »
November 18, 2011
Loughlin responsible for contract manufacturing customers  Read More »
November 18, 2011
Will work to further develop company’s clinical data solution  Read More »
November 17, 2011
Expands Affymetrix portfolio for biomarker discovery  Read More »
November 17, 2011
Funds will support research efforts for TB therapies  Read More »
November 17, 2011
Stabilization was observed in 98% of patients  Read More »
November 17, 2011
Aims to advance development of candidates for CNS disorders  Read More »
November 16, 2011
Also passes sixth product PAI  Read More »
November 16, 2011
Tucat to manage CRO’s market growth  Read More »
November 16, 2011
DOCS opens four new offices  Read More »
November 16, 2011
Will focus efforts on most common mutation in CF patients  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On